Vaccine effectiveness against influenza A(H3N2)-associated hospitalized illness: United States, 2022
Clinical infectious diseases
Open Access Publication
Rights and Permissions
Mark W Tenforde, Manish M Patel, Nathaniel M Lewis, Katherine Adams, Manjusha Gaglani, Jay S Steingrub, Nathan I Shapiro, Abhijit Duggal, Matthew E Prekker, Ithan D Peltan, David N Hager, Michelle N Gong, Matthew C Exline, Adit A Ginde, Nicholas M Mohr, Christopher Mallow, Emily T Martin, H Keipp Talbot, Kevin W Gibbs, Jennie H Kwon, James D Chappell, Natasha Halasa, Adam S Lauring, Christopher J Lindsell, Sydney A Swan, Kimberly W Hart, Kelsey N Womack, Adrienne Baughman, Carlos G Grijalva, Wesley H Self, for the Influenza and Other Viruses in the Acutely Ill (IVY) Network, Vaccine Effectiveness Against Influenza A(H3N2)–Associated Hospitalized Illness: United States, 2022, Clinical Infectious Diseases, Volume 76, Issue 6, 15 March 2023, Pages 1030–1037, https://doi.org/10.1093/cid/ciac869. https://academic.oup.com/cid/article/76/6/1030/6795261?login=true. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Tenforde, Mark W; Kwon, Jennie H; and et al., "Vaccine effectiveness against influenza A(H3N2)-associated hospitalized illness: United States, 2022." Clinical infectious diseases. 76, 6. 1030 - 1037. (2023).
ICTS (Institute of Clinical and Translational Sciences)
Supplemental material is available for this article at publisher site.